MR spectroscopy in post-treatment follow up of brain tumors

Bonavita, 1999, Proton MRS in neurological disorders, Eur J Radiol, 30, 125, 10.1016/S0720-048X(99)00051-0 Kumar, 2000, Malignant gliomas: MR imaging spectrum of radiation therapy and chemotherapy-induced necrosis of the brain after treatment, Radiology, 217, 377, 10.1148/radiology.217.2.r00nv36377 Tzika, 2002, Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging, AJNR, 23, 322 Yang, 2002, Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI, Neuroradiology, 44, 656, 10.1007/s00234-002-0816-9 Bulakbasi, 2003, Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors, AJNR, 24, 225 Byrne, 1994, Imaging of gliomas, Semin Oncol, 21, 162 Earnest, 1998, Cerebral astrocytomas: histopathologic correlation of MR and CT-contrast enhancement with stereotaxic biopsy, Radiology, 166, 823, 10.1148/radiology.166.3.2829270 Yang, 2009, New advances that enable identification of glioblastoma recurrence, Nat Rev Clin Oncol, 6, 648, 10.1038/nrclinonc.2009.150 Smith, 2009, Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions, AJR, 192, 45, 10.2214/AJR.07.3934 Weybright, 2004, MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment, Neuroradiology, 46, 541, 10.1007/s00234-004-1195-1 Weybright, 2005, Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy, AJR, 185, 1471, 10.2214/AJR.04.0933 Zeng, 2007, Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury, J Neuro Oncol, 84, 63, 10.1007/s11060-007-9341-3 Prat, 2010, Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-d-glucose positron emission tomography for detection of recurrence or grade increase in gliomas, J Clin Neurosci, 17, 50, 10.1016/j.jocn.2009.02.035 Dowling, 2001, Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens, AJNR, 22, 604 Rock, 2004, Associations among magnetic resonance spectroscopy, apparent diffusion coefficients and image-guided histopathology with special attention to radiation necrosis, Neurosurgery, 54, 1111, 10.1227/01.NEU.0000119328.56431.A7 Nelson, 2002, In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI, J Magn Reson Imaging, 16, 464, 10.1002/jmri.10183 McKnight, 2002, Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence, J Neurosurg, 97, 794, 10.3171/jns.2002.97.4.0794 Di Costanzo, 2006, Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy, Neuroradiology, 48, 622, 10.1007/s00234-006-0102-3 Chang, 2009, Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma, J Neurooncol, 92, 401, 10.1007/s11060-009-9845-0 Al-Okaili, 2006, Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults, Radiographics, 26, S173, 10.1148/rg.26si065513 Al-Okaili, 2007, Intraaxial brain masses: MR imaging-based diagnostic strategy – initial experience, Radiology, 243, 539, 10.1148/radiol.2432060493 Law, 2004, Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging, Technol Cancer Res Treat, 3, 557, 10.1177/153303460400300605 Hourani, 2008, Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and non-neoplastic brain lesions in adult?, AJNR, 29, 366, 10.3174/ajnr.A0810 Chenevert, 2009, Diffusion imaging for therapy response assessment of brain tumors, Neuroimaging Clin N Am, 19, 559, 10.1016/j.nic.2009.08.009 Wright, 2009, Pattern recognition of MRSI data shows regions of glioma growth that agree with DTI markers of brain tumor infiltration, Magn Reson Med, 62, 1646, 10.1002/mrm.22163 Moller-Hartmann, 2002, Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions, Neuroradiology, 44, 371, 10.1007/s00234-001-0760-0 Callot, 2008, 1H MR spectroscopy of human brain tumors: a practical approach, Eur J Radiol, 67, 268, 10.1016/j.ejrad.2008.02.036 Chong, 2001, Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings, Eur Radiol, 11, 317, 10.1007/s003300000548 Schlemmer, 2001, Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy, AJNR, 22, 1316 Schlemmer, 2002, Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy, Neuroradiology, 44, 216, 10.1007/s002340100703 Kimura, 2001, In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement, NMR Biomed, 14, 339, 10.1002/nbm.711 Narayana, 2007, Use of MR spectroscopy and functional imaging in the treatment planning of gliomas, Br J Radiol, 80, 347, 10.1259/bjr/65349468 Sundgren, 2009, MR spectroscopy in radiation injury, AJNR Sep, 30, 1469, 10.3174/ajnr.A1580 Horská, 2010, Imaging of brain tumors: MR spectroscopy and metabolic imaging, Neuroimaging Clin N Am, 20, 293, 10.1016/j.nic.2010.04.003